These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7058833)

  • 1. Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980.
    Wallace DJ; Podell TE; Weiner JM; Cox MB; Klinenberg JR; Forouzesh S; Dubois EL
    Am J Med; 1982 Feb; 72(2):209-20. PubMed ID: 7058833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical course of lupus nephritis: relationship to the renal histologic findings.
    Pollak VE; Pirani CL; Dujovne I; Dillard MG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1167-81. PubMed ID: 4139685
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively.
    Nossent JC; Bronsveld W; Swaak AJ
    Ann Rheum Dis; 1989 Oct; 48(10):810-6. PubMed ID: 2818017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lupus nephritis with azathioprine.
    Maher JF; Schreiner GE
    Arch Intern Med; 1970 Feb; 125(2):293-8. PubMed ID: 5412919
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic lupus erythematosus with nephritis.
    Morris MC; Cameron JS; Chantler C; Turner DR
    Arch Dis Child; 1981 Oct; 56(10):779-83. PubMed ID: 7305417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisolone treatment of lupus nephritis: Effect of high doses on course of disease, renal function, histological lesions, and immunological reactions.
    Mackay IR; Robson G; Chan D
    Australas Ann Med; 1970 May; 19(2):123-30. PubMed ID: 4194493
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephritis in systemic lupus erythematosus (natural history, treatment, and pathogenesis).
    Pollak VE; Kant KS
    Ric Clin Lab; 1981; 11(1):1-10. PubMed ID: 7221402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lupus erythematosus: observations on long-term survivors of "suppressive" therapy of lupus nephritis with prednisolone.
    Mackay IR
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1211-7. PubMed ID: 4139686
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of continuous normalization of serum hemolytic complement on the course of lupus nephritis: a five year prospective study.
    Jarrett MP; Sablay LB; Walter L; Barland P; Grayzel AI
    Am J Med; 1981 May; 70(5):1067-72. PubMed ID: 7234873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus Nephritis. Correlations between the clinical course and presence of electron-dense deposits.
    Dillard MG; Tillman RL; Sampson CC
    Lab Invest; 1975 Mar; 32(3):261-9. PubMed ID: 1123909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrod.
    Hariharan S; Pollak VE; Kant KS; Weiss MA; Wadhwa NK
    Clin Nephrol; 1990 Aug; 34(2):61-9. PubMed ID: 2225555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population.
    Mok CC; Lee KW; Ho CT; Lau CS; Wong RW
    Rheumatology (Oxford); 2000 Apr; 39(4):399-406. PubMed ID: 10817773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus nephritis. Clinical course as related to morphologic forms and their transitions.
    Baldwin DS; Gluck MC; Lowenstein J; Gallo GR
    Am J Med; 1977 Jan; 62(1):12-30. PubMed ID: 835580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of L-asparaginase in the treatment of patients with nephritis due to lupus: immediate and midterm effects].
    Pastor EM; Saldanha RV; Cossermelli W; Friedmann AA; Serro-Azul LG
    Rev Paul Med; 1978; 91(1-2):1-5. PubMed ID: 635357
    [No Abstract]   [Full Text] [Related]  

  • 15. The long-term clinical course of systemic lupus erythematosus in end-stage renal disease.
    Coplon NS; Diskin CJ; Petersen J; Swenson RS
    N Engl J Med; 1983 Jan; 308(4):186-90. PubMed ID: 6336825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Outcomes and Risk Factors for Nephritis (Flare/
    Buyon JP; Kim MY; Guerra MM; Lu S; Reeves E; Petri M; Laskin CA; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Sawitzke A; Merrill JT; Stephenson MD; Cohn E; Salmon JE
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):940-946. PubMed ID: 28400421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of "silent" lupus nephritis.
    Bennett WM; Bardana EJ; Norman DJ; Houghton DC
    Am J Kidney Dis; 1982 May; 1(6):359-63. PubMed ID: 7091151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic plasma exchange therapy in SLE nephritis.
    Clark WF; Lindsay RM; Ulan RA; Cordy PE; Linton AL
    Clin Nephrol; 1981 Jul; 16(1):20-3. PubMed ID: 7273493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis.
    Wada Y; Ito S; Ueno M; Nakano M; Arakawa M; Gejyo F
    Nephron Clin Pract; 2004; 98(4):c105-11. PubMed ID: 15627787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.